148 related articles for article (PubMed ID: 31242439)
21. Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism.
Salomone LJ; Howell NL; McGrath HE; Kemp BA; Keller SR; Gildea JJ; Felder RA; Carey RM
Hypertension; 2007 Jan; 49(1):155-61. PubMed ID: 17116755
[TBL] [Abstract][Full Text] [Related]
22. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
Zou LL; Liu J; Jin GZ
Biochem Pharmacol; 1997 Jul; 54(2):233-40. PubMed ID: 9271327
[TBL] [Abstract][Full Text] [Related]
23. N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation.
Su H; Xue Z; Feng Y; Xie Y; Deng B; Yao Y; Tian X; An Q; Yang L; Yao Q; Xue J; Chen G; Hao C; Zhou T
Toxicol Appl Pharmacol; 2019 Dec; 384():114789. PubMed ID: 31669811
[TBL] [Abstract][Full Text] [Related]
24. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats.
Zeng C; Luo Y; Asico LD; Hopfer U; Eisner GM; Felder RA; Jose PA
Hypertension; 2003 Oct; 42(4):787-92. PubMed ID: 12900438
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
Sun BC; Jin GZ
Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
[TBL] [Abstract][Full Text] [Related]
27. Application of a count data model to evaluate the anti-metastatic efficacy of QAP14 in 4T1 breast cancer allografts.
Guo Y; Yong L; Yao Q; Han M; Xue J; Jian W; Zhou T
J Theor Biol; 2023 Jan; 557():111323. PubMed ID: 36273592
[TBL] [Abstract][Full Text] [Related]
28. Increased phosphorylation of DARPP-32 by D1 agonistic action of l-stepholidine in the 6-OHDA-lesioned rat striatum.
Liu J; Guo X; Wang BC; Jin GZ
Sheng Li Xue Bao; 1999 Feb; 51(1):65-72. PubMed ID: 11972178
[TBL] [Abstract][Full Text] [Related]
29. Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells.
Bacic D; Capuano P; Baum M; Zhang J; Stange G; Biber J; Kaissling B; Moe OW; Wagner CA; Murer H
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F740-7. PubMed ID: 15547113
[TBL] [Abstract][Full Text] [Related]
30. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.
O'Connell DP; Ragsdale NV; Boyd DG; Felder RA; Carey RM
Hypertension; 1997 Jan; 29(1 Pt 1):115-22. PubMed ID: 9039090
[TBL] [Abstract][Full Text] [Related]
31. Aberrant D1 and D3 dopamine receptor transregulation in hypertension.
Zeng C; Wang D; Asico LD; Welch WJ; Wilcox CS; Hopfer U; Eisner GM; Felder RA; Jose PA
Hypertension; 2004 Mar; 43(3):654-60. PubMed ID: 14732731
[TBL] [Abstract][Full Text] [Related]
32. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
[TBL] [Abstract][Full Text] [Related]
33. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor.
Gildea JJ; Wang X; Jose PA; Felder RA
Hypertension; 2008 Feb; 51(2):360-6. PubMed ID: 18172057
[TBL] [Abstract][Full Text] [Related]
34. Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines.
Mak CK; Avalos M; Randall PK; Kwan SW; Abell CW; Neumeyer JL; Whisennand R; Wilcox RE
Neuropharmacology; 1996 May; 35(5):549-70. PubMed ID: 8887963
[TBL] [Abstract][Full Text] [Related]
35. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.
Zeng C; Han Y; Huang H; Yu C; Ren H; Shi W; He D; Huang L; Yang C; Wang X; Zhou L; Jose PA
J Hypertens; 2009 May; 27(5):1033-41. PubMed ID: 19293728
[TBL] [Abstract][Full Text] [Related]
36. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension.
Yu P; Asico LD; Luo Y; Andrews P; Eisner GM; Hopfer U; Felder RA; Jose PA
Kidney Int; 2006 Sep; 70(6):1072-9. PubMed ID: 16850019
[TBL] [Abstract][Full Text] [Related]
37. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Dong ZJ; Chen LJ; Jin GZ; Creese I
Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
[TBL] [Abstract][Full Text] [Related]
38. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
[TBL] [Abstract][Full Text] [Related]
39. (-)-Stepholidine promotes proliferation and neuronal differentiation of rat embryonic striatal precursor cells in vitro.
Guo H; Yu Y; Xing L; Jin GZ; Zhou J
Neuroreport; 2002 Nov; 13(16):2085-9. PubMed ID: 12438931
[TBL] [Abstract][Full Text] [Related]
40. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
Martin SW; Broadley KJ
Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
